about
Dietary factors, hormesis and healthPersistent organic pollutants and biomarkers of diabetes risk in a cohort of Great Lakes sport caught fish consumersMetabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidencesGenome-wide meta-analyses identify novel loci associated with n-3 and n-6 polyunsaturated fatty acid levels in Chinese and European-ancestry populations.Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice.Fasting whole blood fatty acid profile and risk of type 2 diabetes in adults: a nested case control study.Adherence to an (n-3) fatty acid/fish intake pattern is inversely associated with metabolic syndrome among Puerto Rican adults in the Greater Boston area.Creatine, L-carnitine, and ω3 polyunsaturated fatty acid supplementation from healthy to diseased skeletal muscle.Differential effects of hypothalamic long-chain fatty acid infusions on suppression of hepatic glucose production.The effect of a lifestyle intervention on metabolic health in young women.Obesity-related metabolic dysfunction in dogs: a comparison with human metabolic syndrome.The use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatmentDietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trialKrill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjectsWe are what we eat. The link between diet, evolution and non-genetic inheritanceThe beneficial effects of n-3 polyunsaturated fatty acids on diet induced obesity and impaired glucose control do not require Gpr120.Adipose tissue n-3 fatty acids and metabolic syndromeFish oil consumption prevents glucose intolerance and hypercorticosteronemy in footshock-stressed rats.Alpha linolenic acid in maternal diet halts the lipid disarray due to saturated fatty acids in the liver of mice offspring at weaning.Using high-dose omega-3 fatty acid supplements to lower triglyceride levels in 10- to 19-year-oldsDiabetic cardiac autonomic neuropathy: Do we have any treatment perspectives?Metabolic syndrome and obesity in an insect.Greasing the wheels of managing overweight and obesity with omega-3 fatty acids.Fish consumption, long-chain omega-3 polyunsaturated fatty acid intake and risk of metabolic syndrome: a meta-analysisCardiac protein changes in rats after soybean oil treatment: a proteomic study.Eicosapentaenoic and docosahexaenoic acid-enriched high fat diet delays the development of fatty liver in miceAssociations between omega-3 poly-unsaturated fatty acids from fish consumption and severity of depressive symptoms: an analysis of the 2005-2008 National Health and Nutrition Examination SurveyEffects of the Dietary ω3:ω6 Fatty Acid Ratio on Body Fat and Inflammation in Zebrafish (Danio rerio).Omega-3 fatty acids status in human subjects estimated using a food frequency questionnaire and plasma phospholipids levels.Effect of Early Intervention with Omega-3 on Insulin Resistance in Patients Initiated on Olanzapine with either Sodium Valproate or Lithium: A randomized, Double-blind, Placebo-Controlled Trial.Dietary oxidized n-3 PUFA induce oxidative stress and inflammation: role of intestinal absorption of 4-HHE and reactivity in intestinal cells.Effects of EPA and Vitamin E on Serum Enzymatic Antioxidants and Peroxidation Indices in Patients with Type II Diabetes Mellitus.Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissuesA novel FADS1 isoform potentiates FADS2-mediated production of eicosanoid precursor fatty acids.Fat content, energy value and fatty acid profile of donkey milk during lactation and implications for human nutrition.Dietary fat intake and its association with risk of selected components of the metabolic syndrome among rural South Indians.Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial.n-3 Fatty acids and cardiovascular disease: actions and molecular mechanisms.Adipose tissue RNASeq reveals novel gene-nutrient interactions following n-3 PUFA supplementation and evoked inflammation in humans.Effects of Omega-3 Fatty Acids Supplement on Antioxidant Enzymes Activity in Type 2 Diabetic Patients.
P2860
Q24644082-9A703241-5160-421E-8929-17A54F0B6480Q28397815-6BE01E76-1414-4DE1-8294-31BC7BDCA04EQ30234898-2CDBC44E-C79B-4683-AFB5-D1B047DDC4D4Q30277791-57BBE74E-DA7D-4D59-BB12-47BDA4A450ABQ33451202-CEB81233-CD13-438B-B44B-00DB50F43A52Q33591288-952BBAAB-D704-4EBA-904C-31BDEA8336FAQ34119889-6B1721D7-C3F6-4E46-B4F5-4A1C855F2ABCQ34177044-8A5574D2-0C55-47D1-B056-006BAD671FD2Q34215237-52154F99-0071-4C6A-AA3D-B7C85E2E4820Q34264235-048F0CA9-3631-427E-8045-62F5DF0F95D9Q34396898-F256EEE0-0969-4BC7-8AB6-23C0590554CAQ34411758-B29174D9-FFB7-4FF5-B82A-A52A4E3D67CCQ34493034-8BF7CED9-4E91-4FF3-8AB5-A9BE1BC72055Q34623269-5CC43060-F2E7-4A3D-B106-FC32F3C611F9Q34775430-7DF7B85D-DB66-473F-B861-81042B19F7C6Q34776005-563F7ED4-2C38-47E7-B1A2-C9FCE54D4753Q34860352-E79D9AE6-71EB-4827-B43C-47856981D614Q35038527-39D22E30-DA6F-4E4E-8533-BA1CE4F94D42Q35132830-C576F167-5E26-4E17-AE77-D3770652D9B7Q35159268-7DD20C67-F59E-4CC9-AC2B-EB40FF792581Q35179226-10761E12-301F-44F2-A74F-9CBD403D9DE1Q35214796-4EC7850E-D067-4163-887E-AD9B5D45CC1CQ35534153-C082D378-BD1A-45B2-A88C-6788101025ADQ35585811-2F49A6C2-100C-410C-BCB5-FA266068507AQ35609015-BC7314FD-5A55-4A20-BD18-0A348CBE2075Q35700655-D56B4F49-F13C-4567-8CA3-C750DD3F36B9Q35922932-4DFEF1F3-5725-4FE5-AE3C-6B99BCD7ABF5Q35996460-D0351305-6827-481A-A090-2591C96024CEQ36143491-1D9CFDFB-939E-42D8-BFFC-3418A0BEAF2AQ36197756-A8E54C08-B796-426E-92D7-2C1BBA976C37Q36213850-3D176BDC-61E1-4944-A163-EFF4408E0968Q36348604-CCE68CA9-42BF-4ADC-84E8-0AE32C603BCDQ36353394-43AAF234-60FA-4068-ACBB-0C0E26F65A76Q36520417-58C6E128-55D1-426D-B25E-63E8E19589EEQ36535019-64993459-5369-4F16-958F-7829228BD910Q36550301-1EBDDA67-3967-4B71-8677-3B4E8F70C751Q36564507-C247DBC4-871B-4206-9F06-8C1A05E10912Q36661439-9F785439-EF40-4088-BBBB-EA3ED9099167Q36730195-CFA77387-C885-4989-83BC-ECC126A12140Q36853609-8DE8791E-E53B-40C8-A757-88AAAF5E13CD
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
n-3 fatty acids and the metabolic syndrome.
@ast
n-3 fatty acids and the metabolic syndrome.
@en
type
label
n-3 fatty acids and the metabolic syndrome.
@ast
n-3 fatty acids and the metabolic syndrome.
@en
prefLabel
n-3 fatty acids and the metabolic syndrome.
@ast
n-3 fatty acids and the metabolic syndrome.
@en
P2093
P356
P1476
n-3 fatty acids and the metabolic syndrome.
@en
P2093
Laurence Portois
Willy J Malaisse
Yvon A Carpentier
P304
1499S-1504S
P356
10.1093/AJCN/83.6.1499S
P407
P433
P577
2006-06-01T00:00:00Z